Elevated Liver Enzymes After First Hepatitis B Interferon Injection - Gastroenterology and Hepatology

More Info

---

Elevated liver enzymes, specifically SGPT (ALT) and SGOT (AST), can be a common concern for individuals undergoing treatment for hepatitis B, particularly when starting a new therapy such as long-acting interferon. Your situation, where SGPT increased from 109 to 158 and SGOT from 47 to 59 after the first injection, raises valid questions about the implications of these changes.

Firstly, it is important to understand that liver enzymes are indicators of liver inflammation or damage. In the context of hepatitis B treatment, a transient increase in these enzymes can occur as the body responds to the medication. Interferon, for instance, works by stimulating the immune system to attack the hepatitis B virus, which can lead to an inflammatory response in the liver. This response may temporarily elevate liver enzyme levels, particularly in the early stages of treatment.

Your doctor’s reassurance that this is a normal phenomenon is consistent with clinical observations. It is not uncommon for patients to experience fluctuations in liver enzyme levels during the initial phase of antiviral therapy. The liver may react to the viral load reduction and the immune response triggered by the interferon, leading to an increase in enzyme levels before they stabilize. Typically, these levels should begin to normalize within a month or so, as your doctor indicated.

However, it is crucial to monitor these enzyme levels regularly. If the increase is significant or continues to rise, further evaluation may be necessary to rule out other causes of liver enzyme elevation, such as drug toxicity, additional viral infections, or other liver conditions. Regular follow-up blood tests will help ensure that your liver function is being adequately monitored throughout your treatment.

In addition to enzyme levels, your healthcare provider may also consider other factors, such as your overall clinical picture, any symptoms you may be experiencing, and additional liver function tests. This comprehensive approach helps in assessing the liver's health and the effectiveness of the treatment.

It's also worth noting that while elevated liver enzymes can be concerning, they do not always correlate directly with the severity of liver disease. Some patients with chronic hepatitis B may have elevated enzymes without significant liver damage, while others may have normal enzymes with advanced liver disease. Therefore, it is essential to interpret these results in the context of your overall health and medical history.

In conclusion, while the increase in your liver enzymes following the first interferon injection can be a normal response to treatment, it is essential to maintain open communication with your healthcare provider. Regular monitoring and follow-up tests will provide reassurance and help manage any potential concerns. If you experience any new symptoms or have ongoing worries about your liver health, do not hesitate to reach out to your doctor for further evaluation and guidance.